Related Experiment Video
Updated: Feb 26, 2026

An Improved Time- and Labor- Efficient Protocol for Mouse Primary Hepatocyte Isolation
Published on: October 25, 2021
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
Harsimran D Singh1,2, Itziar Otano1, Krista Rombouts2
1Division of Infection and Immunity, UCL, London, UK.
Abstract:
The TRAIL pathway can mediate apoptosis of hepatic stellate cells to promote the resolution of liver fibrosis. However, TRAIL has the capacity to bind to regulatory receptors in addition to death-inducing receptors; their differential roles in liver fibrosis have not been investigated. Here we have dissected the contribution of regulatory TRAIL receptors to apoptosis resistance in primary human hepatic stellate cells (hHSC). hHSC isolated from healthy margins of liver resections from different donors expressed variable levels of TRAIL-R2/3/4 (but negligible TRAIL-R1) ex vivo and after activation. The apoptotic potential of TRAIL-R2 on hHSC was confirmed by lentiviral-mediated knockdown. A functional inhibitory role for TRAIL-R3/4 was revealed by shRNA knockdown and mAb blockade, showing that these regulatory receptors limit apoptosis of hHSC in response to both oligomerised TRAIL and NK cells. A close inverse ex vivo correlation between hHSC TRAIL-R4 expression and susceptibility to apoptosis underscored its central regulatory role. Our data provide the first demonstration of non-redundant functional roles for the regulatory TRAIL receptors (TRAIL-R3/4) in a physiological setting. The potential for these inhibitory TRAIL receptors to protect hHSC from apoptosis opens new avenues for prognostic and therapeutic approaches to the management of liver fibrosis.
Insights
Regulatory TRAIL receptors (TRAIL-R3/4) protect human hepatic stellate cells (hHSC) from apoptosis, impacting liver fibrosis progression. Targeting these receptors may offer new therapeutic strategies for liver fibrosis.
Area of Science:
- Immunology
- Cell Biology
- Hepatology
Background:
- The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) pathway induces apoptosis in hepatic stellate cells (hHSC), aiding liver fibrosis resolution.
- TRAIL interacts with both death-inducing and regulatory receptors, but the roles of regulatory receptors in liver fibrosis remain unclear.
Purpose of the Study:
- To investigate the contribution of regulatory TRAIL receptors to apoptosis resistance in primary human hepatic stellate cells (hHSC).
- To determine the functional roles of TRAIL-R1, TRAIL-R2, TRAIL-R3, and TRAIL-R4 in regulating hHSC apoptosis and liver fibrosis.
Main Methods:
- Primary human hepatic stellate cells (hHSC) were isolated and analyzed for TRAIL receptor expression (TRAIL-R1/2/3/4).
- Lentiviral-mediated knockdown and shRNA knockdown were used to assess the function of TRAIL-R2, TRAIL-R3, and TRAIL-R4.
- Monoclonal antibody (mAb) blockade was employed to inhibit regulatory TRAIL receptors.
Main Results:
- hHSC expressed variable levels of TRAIL-R2/3/4, with negligible TRAIL-R1.
- Knockdown of TRAIL-R2 confirmed its apoptotic potential on hHSC.
- Knockdown and blockade of TRAIL-R3/4 revealed their inhibitory role, limiting hHSC apoptosis induced by TRAIL and NK cells.
- A strong inverse correlation was observed between TRAIL-R4 expression and hHSC apoptosis susceptibility.
Conclusions:
- TRAIL-R3 and TRAIL-R4 act as non-redundant inhibitory receptors, protecting hHSC from apoptosis in a physiological context.
- These findings highlight the critical role of regulatory TRAIL receptors in controlling hHSC apoptosis.
- Targeting inhibitory TRAIL receptors presents novel prognostic and therapeutic opportunities for managing liver fibrosis.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway

